These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 16767905

  • 1. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma.
    Deraco M, De Simone M, Rossi CR, Cavaliere F, Difilippo F, Scuderi S, Pilatti P, Kusamura S.
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):41-5. PubMed ID: 16767905
    [Abstract] [Full Text] [Related]

  • 2. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
    Deraco M, De Simone M, Rossi CR, Cavaliere F, Di Filippo F, Vaira M, Piatti P, Kusamura S.
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904
    [Abstract] [Full Text] [Related]

  • 3. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
    Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras Ad AD, Kusamura S.
    Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
    [Abstract] [Full Text] [Related]

  • 4. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
    Kusamura S, Deraco M, Baratti D, Inglese MG, Costanzo P, Favaro M, Manzi R, Gavazzi C.
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):207-12. PubMed ID: 16767933
    [Abstract] [Full Text] [Related]

  • 5. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
    Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S.
    J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
    [Abstract] [Full Text] [Related]

  • 6. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
    Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M.
    Cancer; 2006 Mar 01; 106(5):1144-53. PubMed ID: 16456817
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A, Borzellino G, Momo EN, Segattini C, Pitoni F, Steccanella F, De Manzoni G.
    Ann Ital Chir; 2008 Mar 01; 79(4):231-9. PubMed ID: 19093624
    [Abstract] [Full Text] [Related]

  • 8. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei.
    Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S.
    Ann Surg Oncol; 2004 Apr 01; 11(4):393-8. PubMed ID: 15070599
    [Abstract] [Full Text] [Related]

  • 9. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2790-7. PubMed ID: 17661150
    [Abstract] [Full Text] [Related]

  • 10. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
    Cavaliere F, Di Filippo F, Botti C, Cosimelli M, Giannarelli D, Aloe L, Arcuri E, Aromatario C, Consolo S, Callopoli A, Laurenzi L, Tedesco M, Di Angelo P, Giunta S, Cavaliere R.
    Eur J Surg Oncol; 2000 Aug 01; 26(5):486-91. PubMed ID: 11016471
    [Abstract] [Full Text] [Related]

  • 11. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.
    In Vivo; 2009 Aug 01; 23(4):639-44. PubMed ID: 19567401
    [Abstract] [Full Text] [Related]

  • 12. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
    Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard AC, Isaac S, Gilly FN, Glehen O.
    Ann Surg Oncol; 2006 Mar 01; 13(3):405-12. PubMed ID: 16485159
    [Abstract] [Full Text] [Related]

  • 13. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.
    Ann Surg Oncol; 2009 Feb 01; 16(2):463-72. PubMed ID: 19082859
    [Abstract] [Full Text] [Related]

  • 14. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Baratti D, Vaira M, Kusamura S, D'Amico S, Balestra MR, Cioppa T, Mingrone E, De Simone M, Deraco M.
    Eur J Surg Oncol; 2010 Nov 01; 36(11):1047-53. PubMed ID: 20832234
    [Abstract] [Full Text] [Related]

  • 15. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
    Yang XJ, Li Y, al-shammaa Hassan AH, Yang GL, Liu SY, Lu YL, Zhang JW, Yonemura Y.
    Ann Surg Oncol; 2009 Feb 01; 16(2):345-51. PubMed ID: 19018599
    [Abstract] [Full Text] [Related]

  • 16. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.
    Gilly FN, Beaujard A, Glehen O, Grandclement E, Caillot JL, Francois Y, Sadeghi-Looyeh B, Gueugniaud PY, Garbit F, Benoit M, Bienvenu J, Vignal J.
    Anticancer Res; 1999 Feb 01; 19(3B):2317-21. PubMed ID: 10472351
    [Abstract] [Full Text] [Related]

  • 17. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E, Greenberg R, Avital S, Skornick Y, Schneebaum S.
    Isr Med Assoc J; 2007 Nov 01; 9(11):787-90. PubMed ID: 18085034
    [Abstract] [Full Text] [Related]

  • 18. [The Czech experience in peritonectomy and hyperthermic perioperative cytostatic lavage in the treatment of peritoneal malignancy].
    Antos F, Serclova Z, Gilbert Z, Skala M, Vitek P.
    Zentralbl Chir; 2004 Apr 01; 129(2):153-6. PubMed ID: 15106050
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
    Chua TC, Yan TD, Morris DL.
    J Surg Oncol; 2009 Feb 01; 99(2):109-13. PubMed ID: 19016259
    [Abstract] [Full Text] [Related]

  • 20. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan.
    Raspagliesi F, Kusamura S, Campos Torres JC, de Souza GA, Ditto A, Zanaboni F, Younan R, Baratti D, Mariani L, Laterza B, Deraco M.
    Eur J Surg Oncol; 2006 Aug 01; 32(6):671-5. PubMed ID: 16621425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.